Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells
Open Access
- 30 December 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (1), 314
- https://doi.org/10.3390/ijms22010314
Abstract
Background: The combination of the unique properties of cancer cells makes it possible to find specific ligands that interact directly with the tumor, and to conduct targeted tumor therapy. Phage display is one of the most common methods for searching for specific ligands. Bacteriophages display peptides, and the peptides themselves can be used as targeting molecules for the delivery of diagnostic and therapeutic agents. Phage display can be performed both in vitro and in vivo. Moreover, it is possible to carry out the phage display on cells pre-enriched for a certain tumor marker, for example, CD44 and CD133. Methods: For this work we used several methods, such as phage display, sequencing, cell sorting, immunocytochemistry, phage titration. Results: We performed phage display using different screening systems (in vitro and in vivo), different phage libraries (Ph.D-7, Ph.D-12, Ph.D-C7C) on CD44+/CD133+ and without enrichment U-87 MG cells. The binding efficiency of bacteriophages displayed tumor-targeting peptides on U-87 MG cells was compared in vitro. We also conducted a comparative analysis in vivo of the specificity of the accumulation of selected bacteriophages in the tumor and in the control organs (liver, brain, kidney and lungs). Conclusions: The screening in vivo of linear phage peptide libraries for glioblastoma was the most effective strategy for obtaining tumor-targeting peptides providing targeted delivery of diagnostic and therapeutic agents to glioblastoma.This publication has 18 references indexed in Scilit:
- Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneityPLOS ONE, 2017
- Tumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of LactaptinPLOS ONE, 2016
- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic TargetStem Cells Translational Medicine, 2015
- In vivo phage display selection of an ovarian cancer targeting peptide for SPECT/CT imaging.2014
- CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic nichesExperimental Biology and Medicine, 2013
- Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptidesFuture Medicinal Chemistry, 2012
- Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinomaExperimental and Molecular Pathology, 2010
- Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial TumorsClinical Cancer Research, 2009
- CD133 Is a Marker of Bioenergetic Stress in Human GliomaPLOS ONE, 2008
- CD133+CD44+ Population Efficiently Enriches Colon Cancer Initiating CellsAnnals of Surgical Oncology, 2008